Sacomni 50 — 24 mg Sacubitril and 26 mg Valsartan as sodium salt complex, along with approved excipients
Sacomni 50 by EMK Omni Pharma is a prescription-based Sacubitril and Valsartan Tablets formulation used for doctor-supervised heart failure management...

What is Sacomni 50?
Sacomni 50 is a pharmaceutical product manufactured and marketed by EMK Omni Pharma, a trusted pharmaceutical company based in Mysuru, Karnataka. It belongs to the Blood Pressure Management therapeutic category and is available as a Tablet formulation.
Sacomni 50 by EMK Omni Pharma is a prescription-based Sacubitril and Valsartan Tablets formulation used for doctor-supervised heart failure management, cardiac function support and cardiovascular health care. Each film-coated tablet contains Sacubitril 24 mg and Valsartan 26 mg as sodium salt complex. Sacomni 50 is commonly prescribed by healthcare professionals for patients who require support in managing heart failure, cardiac workload, blood pressure control and long-term heart health. Sacomni 50 Sacubitril 24 mg and Valsartan 26 mg Tablets by EMK Omni Pharma are designed for physician-guided cardiac care where heart failure support, vascular health, blood pressure management and cardiovascular risk management are required. This medicine should be used only as advised by a registered medical practitioner.
Composition & Active Ingredients
Each tablet of Sacomni 50 contains the following active pharmaceutical ingredients:
Active Composition: 24 mg Sacubitril and 26 mg Valsartan as sodium salt complex, along with approved excipients
Dosage Strength: 24 mg & 26 mg
Medicine Type: Tablet
Pack Size: 10 X 14 Tablets
The formulation is prepared with approved excipients to ensure optimal stability, bioavailability, and therapeutic efficacy. All ingredients comply with Indian Pharmacopoeia (IP) standards where applicable.
Therapeutic Category — Blood Pressure Management
Sacomni 50 is classified under the Blood Pressure Management therapeutic category. This category encompasses medicines that are commonly prescribed by healthcare professionals for conditions related to hypertension, blood pressure control, heart rate regulation, cardiac workload reduction, and vascular health.
Sacomni 50 may be prescribed by doctors for patients who require support in managing heart failure, cardiac strain, blood pressure concerns and cardiovascular health risks. It may be used as part of a physician-guided heart care plan where cardiac function support, vascular balance and long-term cardiovascular management are required. Sacomni 50 by EMK Omni Pharma is suitable for doctor-supervised treatment where heart failure management, cardiac health support and blood pressure control are needed. Patients should not self-medicate, change the dosage, stop the medicine or combine it with other heart medicines without consulting their doctor. As mentioned on the product label, Valsartan should be discontinued as soon as pregnancy is detected, and patients must consult their physician immediately in such cases.
Dosage Strength & Formulation
Sacomni 50 is formulated as a Tablet with a dosage strength of 24 mg & 26 mg. It is available in a pack size of 10 X 14 Tablets.
This product is designed for oral administration and should be taken exactly as prescribed by a registered medical practitioner. Patients should not alter the dosage, crush, chew, or break the tablet unless specifically instructed by their physician.
Important: The dosage and duration of treatment are determined by the prescribing physician based on the patient's individual medical condition, age, weight, and response to treatment.
Storage Instructions
Proper storage of pharmaceutical products is essential to maintain their quality, potency, and safety. Sacomni 50 should be stored according to the following guidelines:
Sacomni 50 Sacubitril and Valsartan Tablets should be stored in a cool, dry and dark place at a temperature below 25°C.
General Storage Guidelines:
Prescription & Regulatory Information
Sacomni 50 is a prescription-based pharmaceutical product. It must only be dispensed and used under the guidance of a registered medical practitioner.
Prescription Warning: Schedule H Prescription Drug - Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
This medicine is regulated under Indian pharmaceutical laws and is subject to Schedule H / Schedule G drug regulations as applicable. It should not be purchased or used without a valid prescription from a licensed healthcare professional.
For Healthcare Professionals: Sacomni 50 is available through authorised pharmaceutical distribution channels. For product availability, pricing, and distribution enquiries, please contact EMK Omni Pharma directly.
Caution, Safety & Important Warnings
Caution Details: Keep out of reach of children. Consult your physician if you experience any adverse effects.
General Safety Information:
About EMK Omni Pharma
EMK Omni Pharma is a trusted pharmaceutical company based in Mysuru, Karnataka, operating as Under the visionary leadership of Kumara Swamy, the company is committed to providing high-quality, physician-guided pharmaceutical products across multiple therapeutic areas.
Our product portfolio includes medicines for Cardiac Care, Cholesterol & Lipid Care, Blood Pressure Management, Nutritional Supplements, Pain Management, and Diabetes Care, all formulated to meet established pharmaceutical quality standards. EMK Omni Pharma works closely with healthcare professionals, pharmacies, hospitals, and distribution partners to ensure that quality medicines reach those who need them — safely, reliably, and responsibly.
Office Address: 2nd Floor, Room No. 01, 102A, Panchamantra Rd, above Kumar Medicals, Kuvempu Nagara, Mysuru, Karnataka 570023
Email: info@emkomnipharma.com
Medical Disclaimer
The information provided on this page is intended for general educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations.
This product information should not be used as a substitute for professional medical advice. Always consult a qualified and registered medical practitioner before starting, stopping, or changing any medication. Self-medication can be harmful and may lead to serious health consequences.
EMK Omni Pharma does not make any therapeutic claims about curing, treating, or preventing any disease without proper clinical evidence and regulatory approval. All products are intended for use only under proper medical supervision.
The product details, composition, and usage guidelines mentioned here are based on the manufacturer's product information and are subject to change. For the most current product information, please refer to the actual product packaging or consult your healthcare provider.
Related Articles
Medical Disclaimer
This product information is intended for general awareness only and should not be considered medical advice. Please consult a registered medical practitioner before using any prescription medicine.


